Sean Dodge
Stock Analyst at BMO Capital
(2.03)
# 2,984
Out of 5,172 analysts
157
Total ratings
34.51%
Success rate
-5.07%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVAH Aveanna Healthcare Holdings | Maintains: Outperform | $11 → $10 | $6.52 | +53.37% | 2 | Mar 20, 2026 | |
| OMDA Omada Health | Maintains: Outperform | $27 → $18 | $13.51 | +33.23% | 2 | Mar 6, 2026 | |
| TDOC Teladoc Health | Maintains: Market Perform | $8 → $5 | $5.35 | -6.54% | 18 | Feb 26, 2026 | |
| MDLN Medline | Maintains: Outperform | $45 → $54 | $42.73 | +26.37% | 2 | Feb 26, 2026 | |
| WAY Waystar Holding | Maintains: Outperform | $47 → $30 | $24.07 | +24.64% | 4 | Feb 18, 2026 | |
| SHC Sotera Health Company | Reinstates: Outperform | $24 | $13.50 | +77.78% | 12 | Jan 9, 2026 | |
| BTSG BrightSpring Health Services | Initiates: Outperform | $40 | $41.21 | -2.94% | 1 | Nov 13, 2025 | |
| HQY HealthEquity | Initiates: Market Perform | $100 | $81.02 | +23.43% | 13 | Nov 13, 2025 | |
| ADUS Addus HomeCare | Initiates: Market Perform | $120 | $99.28 | +20.87% | 1 | Nov 13, 2025 | |
| EVH Evolent Health | Initiates: Outperform | $7 | $2.58 | +171.32% | 10 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $260 | $166.07 | +56.56% | 7 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $9 | $6.15 | +46.34% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $32 | $11.86 | +169.81% | 16 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $300 | $184.07 | +62.98% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $8 | $6.40 | +25.00% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $30 | $21.24 | +41.24% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $20 | $18.97 | +5.43% | 14 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $55 | $24.41 | +125.32% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $175 | $99.70 | +75.53% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $600 | $452.51 | +32.59% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $7 → $6 | $1.23 | +387.80% | 10 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $3 → $3.5 | $0.43 | +721.02% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $7 → $6 | $5.99 | +0.17% | 11 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $15.30 | -8.50% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $2.03 | +392.61% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $210.14 | -84.30% | 1 | Sep 14, 2022 |
Aveanna Healthcare Holdings
Mar 20, 2026
Maintains: Outperform
Price Target: $11 → $10
Current: $6.52
Upside: +53.37%
Omada Health
Mar 6, 2026
Maintains: Outperform
Price Target: $27 → $18
Current: $13.51
Upside: +33.23%
Teladoc Health
Feb 26, 2026
Maintains: Market Perform
Price Target: $8 → $5
Current: $5.35
Upside: -6.54%
Medline
Feb 26, 2026
Maintains: Outperform
Price Target: $45 → $54
Current: $42.73
Upside: +26.37%
Waystar Holding
Feb 18, 2026
Maintains: Outperform
Price Target: $47 → $30
Current: $24.07
Upside: +24.64%
Sotera Health Company
Jan 9, 2026
Reinstates: Outperform
Price Target: $24
Current: $13.50
Upside: +77.78%
BrightSpring Health Services
Nov 13, 2025
Initiates: Outperform
Price Target: $40
Current: $41.21
Upside: -2.94%
HealthEquity
Nov 13, 2025
Initiates: Market Perform
Price Target: $100
Current: $81.02
Upside: +23.43%
Addus HomeCare
Nov 13, 2025
Initiates: Market Perform
Price Target: $120
Current: $99.28
Upside: +20.87%
Evolent Health
Nov 13, 2025
Initiates: Outperform
Price Target: $7
Current: $2.58
Upside: +171.32%
Nov 13, 2025
Initiates: Outperform
Price Target: $260
Current: $166.07
Upside: +56.56%
Nov 13, 2025
Initiates: Market Perform
Price Target: $9
Current: $6.15
Upside: +46.34%
Nov 13, 2025
Initiates: Outperform
Price Target: $32
Current: $11.86
Upside: +169.81%
Nov 13, 2025
Initiates: Market Perform
Price Target: $300
Current: $184.07
Upside: +62.98%
Nov 13, 2025
Initiates: Outperform
Price Target: $8
Current: $6.40
Upside: +25.00%
Nov 13, 2025
Initiates: Outperform
Price Target: $30
Current: $21.24
Upside: +41.24%
Nov 13, 2025
Initiates: Market Perform
Price Target: $20
Current: $18.97
Upside: +5.43%
Nov 13, 2025
Initiates: Market Perform
Price Target: $55
Current: $24.41
Upside: +125.32%
Nov 13, 2025
Initiates: Market Perform
Price Target: $175
Current: $99.70
Upside: +75.53%
Nov 13, 2025
Initiates: Market Perform
Price Target: $600
Current: $452.51
Upside: +32.59%
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $1.23
Upside: +387.80%
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $0.43
Upside: +721.02%
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $5.99
Upside: +0.17%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $15.30
Upside: -8.50%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $2.03
Upside: +392.61%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $210.14
Upside: -84.30%